Optimer Pharmaceutical is in trials, and is working with Par Pharmaceuticals, and has 2 promising drugs. They are focusing on narrow-spectrum drugs to better target CDiff. This sounds quite promising.
http://www.signonsandiego.com/news/business/biotech/20060217-9999-1b17tech.html
Optimer Pharmaceutical
Who is online
Users browsing this forum: No registered users and 48 guests